⌘K

Login Start Free

Home/Filings/4/0001214659-22-004374

4//SEC Filing

Chang David D 4

Accession 0001214659-22-004374

CIK 0001737287other

View on SEC.gov Company Profile

Filed

Mar 24, 8:00 PM ET

Accepted

Mar 25, 5:51 PM ET

Size

5.4 KB

Accession

0001214659-22-004374

Insider Transaction Report

Form 4

Period: 2022-03-23

Allogene Therapeutics, Inc.ALLO

DirectorPresident and CEO

Transactions

Award
Stock Option (Right to Buy)
2022-03-23+2,195,512→ 2,195,512 total
Exercise: $9.69Exp: 2032-03-23→ Common Stock (2,195,512 underlying)

Footnotes (1)

[F1]25% of the shares subject to the stock option shall vest on March 13, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter

Documents

1 file

4
marketforms-55851.xmlPrimary
PRIMARY DOCUMENT

Issuer

Allogene Therapeutics, Inc.

CIK 0001737287

Entity typeother

Related Parties

1

filerCIK 0001611024

Filing Metadata

Form type: 4
Filed: Mar 24, 8:00 PM ET
Accepted: Mar 25, 5:51 PM ET
Size: 5.4 KB

View on SEC.gov